New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells
Eva Gottfried(University of Regensburg), Marina Kreutz(University of Regensburg)
Cited by 118
Related Papers
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
|Frontiers in Immunology|2017|367
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy
|Cell Reports|2019|297
Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages
|Virology|2006|71
D-2-Hydroxyglutarate and L-2-Hydroxyglutarate Inhibit IL-12 Secretion by Human Monocyte-Derived Dendritic Cells
|International Journal of Molecular Sciences|2019|27
LDHB Overexpression Can Partially Overcome T Cell Inhibition by Lactic Acid
|International Journal of Molecular Sciences|2022|27